Monday, March 12, 2012

ADAP Reauthorization: Don't Delay!

If you're following ADAP figures, you're likely know people who rely on ADAP for their HIV medications.

Please encourage them to submit their applications for re-authorization ASAP to help avoid delays, as requested by the NCDHHS, which wrote:

Last year almost 40% of the applications were received in the last 15 days of reauthorization. This resulted in delayed processing and interruptions in medication for many clients. Please help your clients avoid an interruption in medication by sending their applications in as early in March as possible. We can not allow clients to receive medications from ADAP/SPAP if their reauthorization paperwork has not been completely processed.

You can find more information about ADAP reauthorization on the NC Department of Health and Human Services website.

Now, on to the latest numbers:

As of March 8, 2012 there are:

  • 6,740 individuals enrolled in HIV/AIDS drug assistance programs (ADAP & SPAP)
    • 6,070 are enrolled in ADAP
    • 670 are enrolled in SPAP
  • 155 individuals on the waiting list

As of March 1, 2012 there were:

  • 6,708 individuals enrolled in HIV/AIDS drug assistance programs (ADAP & SPAP)
    • 6,086 are enrolled in ADAP
    • 622 are enrolled in SPAP
  • 153 individuals on the waiting list

This week our overall enrollment increased as it always does but there was a decrease in ADAP enrollment and an increase in SPAP enrollment. This is a result of the state's enhanced efforts to identify clients on ADAP who are enrolled in a Medicare Part D plan and switch those clients to SPAP. As these efforts continu it is likely that the ratio of ADAP to SPAP clients will continue to change.

According to NASTAD’s most recent ADAP Watch, there are 11 states with waiting lists, totaling 3,949 people. That report shows NC as having 155 clients on the waiting list, which was our official count at COB on March 7. NC accounts for approximately 4% of the national ADAP waiting list. NASTAD’s ADAP Watch can be found at http://www.nastad.org/default.aspx.

No comments:

Post a Comment